Short answer
OMNICELL, INC. (OMCL) filed its Q2 2026 10-Q quarterly report on Aug 5, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $312M (up 7.4% year over year) with net income of $24M.
Q2 2026 key financials · XBRL
- Revenue
- $312M
- +7.4% YoY · +0.8% QoQ
- Net income
- $24M
- +330.7% YoY · +113.8% QoQ
- Operating margin
- 10.4%
- Gross margin
- 49.0%
- EPS (diluted)
- $0.52
- +333.3% YoY · +108.0% QoQ
Source: XBRL data from the OMNICELL, INC. (OMCL) Q2 2026 10-Q on SEC EDGAR. USD.
OMNICELL, INC. Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Single operating segment managed at consolidated level; no best or worst product-line performance disclosed
- Q2 tariff refunds $14.5 million, recorded primarily as reduced product-revenue costs
- Replacement tariffs 10%–12.5%; management expects no material near-term impact, but cost and supply-chain risks remain
- Expected headwinds: $910 billion Medicaid reduction, tariffs, labor shortages, and compressed operating margins
Risk Factors
- No risk-factors section provided; submitted text contains Items 2–6 only
- No newly added risk factor or 10-K comparison disclosed
- No regulatory, legal, operational, competitive, market, liquidity, debt, currency, or concentration risks stated
- No share repurchases during quarter, limiting disclosed capital-return activity
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other OMNICELL, INC. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.